ChromaDex completes pterostilbene UV trial

US naturals firm ChromaDex has announced the completion of an animal skincare study of pterostilbene, which the firm says shows that the substance prevents skin damage from UV exposure

US naturals firm ChromaDex has announced the completion of an animal skincare study of pterostilbene, which the firm says shows that the substance prevents skin damage from UV exposure.

. . .

This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.

Or

Subscribe now to premium content on Cosmetics Business

Companies